1-6 of 6
Apostolia Maria Tsimberidou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses

Free
Apostolia-Maria Tsimberidou, Sijin Wen, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Kenneth Aldape, Yang Ye, Razelle Kurzrock, Donald Berry
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4827–4836.
https://doi.org/10.1158/1078-0432.CCR-14-0603
Published: 14 September 2014
View articletitled, Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses
Open the PDF for Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses in another window
Includes: Supplementary data
Journal Articles

Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors

Free
David Hong, Rabih Said, Gerald Falchook, Aung Naing, Stacy Moulder, Apostolia-Maria Tsimberidou, Gerald Galluppi, Naveen Dakappagari, Chris Storgard, Razelle Kurzrock, Lee S. Rosen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4824–4831.
https://doi.org/10.1158/1078-0432.CCR-13-0477
Published: 02 September 2013
View articletitled, Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors
Open the PDF for Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Free
Apostolia-Maria Tsimberidou, Nancy G. Iskander, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Rajyalakshmi Luthra, Yang Ye, Sijin Wen, Donald Berry, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6373–6383.
https://doi.org/10.1158/1078-0432.CCR-12-1627
Published: 14 November 2012
View articletitled, Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Open the PDF for Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative in another window
Includes: Supplementary data
Journal Articles

Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience

Free
Apostolia Maria Tsimberidou, Katherine Letourneau, Sijin Wen, Jennifer Wheler, David Hong, Aung Naing, Nancy G. Iskander, Cynthia Uehara, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4110–4118.
https://doi.org/10.1158/1078-0432.CCR-10-3095
Published: 15 June 2011
View articletitled, Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience
Open the PDF for Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience in another window
Includes: Supplementary data
Journal Articles

A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors

Free
Apostolia Maria Tsimberidou, Luis H. Camacho, Srdan Verstovsek, Chaan Ng, David S. Hong, Cynthia K. Uehara, Catalina Gutierrez, Shawn Daring, Jan Stevens, Philip B. Komarnitsky, Brian Schwartz, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4769–4776.
https://doi.org/10.1158/1078-0432.CCR-08-2984
Published: 15 July 2009
View articletitled, A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors
Open the PDF for A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors in another window
Journal Articles

The Prognostic Significance of Serum β2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients

Free
Apostolia-Maria Tsimberidou, Hagop M. Kantarjian, Sijin Wen, Susan O'Brien, Jorge Cortes, William G. Wierda, Charles Koller, Sherry Pierce, Mark Brandt, Emil J. Freireich, Michael J. Keating, Elihu H. Estey
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 721–730.
https://doi.org/10.1158/1078-0432.CCR-07-2063
Published: 01 February 2008
View articletitled, The Prognostic Significance of Serum β2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients
Open the PDF for The Prognostic Significance of Serum β2 Microglobulin Levels in Acute Myeloid Leukemia and Prognostic Scores Predicting Survival: Analysis of 1,180 Patients in another window